HIC specializes in the creation of innovative technologies. The company is recognized fort its innovative breath analysis solutions, especially in non-communicable diseases (NCDs) such as emergent diseases, Covid-19.
After 12 years of intensive research, HIC's hallmark product is the Breath NCDs Analyzer. The device analyzes NCDs-related biomarkers in a patient's breath and provides accurate, real-time results without invasive procedures or specialized training.
In addition, HIC has contributed to the fight against Covid-19 by devising a breath analyzer capable of detecting Covid-19 biomarkers in a patient's breath, thereby providing a rapid and
accurate diagnostic tool for the disease.
Mission
Researching and developing medical devices that access
health conditions through respiratory analysis.
Vision
Empowering everyone with the ability to monitor their health via
